Factors associated with mortality and graft failure in liver transplants: A hierarchical approach

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Haddad, Luciana ^a   Cassenote, Alex Jones Flores ^a   Andraus, Wellington ^a   De Martino, Rodrigo Bronze ^a   De Siqueira Ortega, Neli Regina ^a   Abe, Jair Minoro ^a   D'Albuquerque, Luiz Augusto Carneiro ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; DOBUTAMINE;

ADULT; AGE; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY SURFACE; BRAZIL; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; DRUG USE; FEMALE; GENDER; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; INCIDENCE; INTENSIVE CARE; INTUBATION; LABORATORY TEST; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; DISEASE FREE SURVIVAL; END STAGE LIVER DISEASE; GRAFT REJECTION; MIDDLE AGED; MULTIVARIATE ANALYSIS; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA;

ADULT; BRAZIL; DISEASE-FREE SURVIVAL; END STAGE LIVER DISEASE; FEMALE; GRAFT REJECTION; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84942896694     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0134874     Document Type: Article

References (43)

1. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006; 6: 783-790. PMID: 16539636
2. Dutkowski P, Oberkofler CE, Slankamenac K, Puhan MA, Schadde E, Mullhuapt B, et al. Are there better guidelines for allocation in liver transplantation? Ann Surg. 2011; 254: 745-754. doi: 10.1097/SLA. 0b013e3182365081 PMID: 22042468
3. Rana A, Hardy MA, Halazun KJ, Woodland DC, Ratner LE, Samstein B, et al. Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant. 2008; 8: 2537-2546. doi: 10.1111/j.1600-6143.2008.02400.x PMID: 18945283
4. Kamath P. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001; 33: 464-470. PMID: 11172350
5. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant. 2009; 9: 318-326. doi: 10.1111/j.1600-6143.2008.02491.x PMID: 19120079
6. Associação Brasileira de Transplantes de Órgãos (ABTO). Dimensionamento dos transplantes no Brasil e em cada estado. Sao Paulo: ABTO; 2014.
7. Abbad G, Torres CV. Regressão múltipla stepwise e hierárquica em Psicologia Organizacional: aplicações, problemas e soluções. Estudos de Psicologia. 2002; 7: 19-29.
8. Victora CG, Huttly SR, Fuchs SC, Olinto MT. The role of conceptual frameworks in epidemiological analysis: a hierarchical approach. Int J Epidemiol. 1997; 26: 224-227. PMID: 9126524
9. Daniel WW. Biostatistics: a foundation for analysis in the health sciences. New York: Wiley; 2009.
10. Manish KG, Pardeep K, Jugal K. Understanding survival analysis: Kaplan-Meier estimate. Int J Ayurveda Res. 2010; 1: 274-278. PMID: 21455458
11. Fay MP. (n.d.). Exact p-values and matching confidence intervals for simple discrete parametric cases. Available: http://cran.r-project.org/web/packages/exactci/exactci.pdf. Accessed 06 July 2014.
12. Geyer JC. Generalized linear models in R. Available: http://www.stat.umn.edu/geyer/5931/mle/glm.pdf. Accessed 06 July 2014.
13. Atkinson AC, Riani M. Robust diagnostic regression analysis. New York: Springer; 2000.
14. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. New York: John Wiley & Sons; 2003. New York.
15. Hair JF Jr, Black WC, Babin BJ, Anderson RE. Multivariate data analysis. 7th ed. Upper Saddle River, NJ: Prentice Hall; 2010.
16. Posada D, Buckley TR. Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst Biol. 2004; 53: 793-808. PMID: 15545256
17. Freeman RB, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merion RM. Improving liver allocation: MELD and PELD. Am J Transplant. 2004' 4: 114-131. PMID: 15113360
18. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, et al. Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology. 2003; 124: 91-96. PMID: 12512033
19. Åberg F, Isoniemi H, Höckerstedt K. Long-term results of liver transplantation. Scand J Surg. 2011; 100: 14-21. PMID: 21482501
20. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl. 2004; 10: 886-897. PMID: 15237373
21. Quante M, Benckert C, Thelen A, Jonas S. Experience since MELD implementation: how does the new system deliver? Int J Hepatol. 2012; 2012: 264015. doi: 10.1155/2012/264015 PMID: 23091734
22. Siciliano M, Parlati L, Maldarelli F, Rossi M, Corradini SG. Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther. 2012; 3: 49-61. doi: 10.4292/wjgpt.v3.i4.49 PMID: 22966483
23. Schaubel DE, Sima CS, Goodrich NP, Feng S, Merion RM. The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant. 2008; 8: 419-425. doi: 10.1111/j.1600-6143.2007.02086.x PMID: 18190658
24. Ravaioli M, Grazi GL, Dazzi A, Bertuzzo V, Ercolani G, Cescon M, et al. Survival benefit after liver transplantation: a single European center experience. Transplantation. 2009; 88: 826-834. doi: 10.1097/ TP.0b013e3181b26807 PMID: 19920783
25. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, et al. The survival benefit of liver transplantation. Am J Transplant. 2005; 5: 307-313. PMID: 15643990
26. Bonney GK, Aldersley MA, Asthana S, Toogood GJ, Pollard SG, Lodge JP, et al. Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation. 2009; 87: 1858-1863. doi: 10.1097/TP.0b013e3181a75b37 PMID: 19543065
27. Wang ZX, Yan LN, Wang WT, Xu MQ, Yang JY. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure. Transplant Proc. 2007; 39: 1501-1504. PMID: 17580172
28. Saab S. MELD score predicts 1-year patient survival post-orthotopic liver transplantation. Liver Transpl. 2003; 9: 473-476. PMID: 12740789
29. Santori G, Andorno E, Morelli N, Casaccia M, Bottino G, Ghirelli R, et al. Model for end-stage liver disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center. Transplant Proc. 2008; 40: 1903-1905. PMID: 18675084
30. Campos ACL, Matias JEF, Coelho JCU. Nutritional aspects of liver transplantation. Curr Opin Clin Nutr Metab Care. 2002; 5: 297-307. PMID: 11953656
31. Weismüller TJ, Prokein J, Becker T, Barg-Hock H, Klempnauer J, Manns MP, et al. Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol. 2009; 43: 736-746.
32. Ghobrial RM, Gornbein J, Steadman R, Danino N, Markmann JF, Holt C, et al. Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg. 2002; 236: 315-322; discussion 322-323. PMID: 12192318
33. Reddy MS, Varghese J, Venkataraman J, Rela M. Matching donor to recipient in liver transplantation: relevance in clinical practice. World J Hepatol. 2013; 5: 603-611. PMID: 24303088
34. Zeier M, Döhler B, Opelz G, Ritz E. The effect of donor gender on graft survival. J Am Soc Nephrol. 2002; 13: 2570-2576. PMID: 12239247
35. Hoofnagle JH, Lombardero M, Zetterman RK, Lake J, Porayko M, Everhart J, et al. Donor age and outcome of liver transplantation. Hepatology. 1996; 24: 89-96. PMID: 8707288
36. Cameron JL, Riall TS, Coleman JA, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006; 244: 10-15. PMID: 16794383
37. Cameron AM, Ghobrial RM, Yersiz H, Farmer DG, Lipshutz GS, Gordon SA, et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1000 liver transplants. Ann Surg. 2006; 243: 748-753; discussion 753-755. PMID: 16772778
38. Tuttle RR, Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res. 1975; 36: 185-196. PMID: 234805
39. Blok JJ, Braat AE, Adam R, Burroughs AK, Putter H, Kooreman NG, et al. Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region. Liver Transpl. 2011; 18: 112-119.
40. Briceño J, Sánchez-Hidalgo JM, Naranjo A, Ciria R, Pozo JC, Luque A, et al. Model for end-stage liver disease can predict very early outcome after liver transplantation. Transplant Proc. 2008; 40: 2952-2954. PMID: 19010157
41. Botelho F, Silva C, Cruz F. Epidemiologia explicada-análise de sobrevivência. Acta Urol. 2009; 26: 33-38.
42. Harrington DP, Fleming TR. Counting processes and survival analysis. New York: Wiley; 2011.
43. Morabia A. On the origin of Hill's causal criteria. Epidemiology. 1991; 2: 367- PMID: 1742387